PLD2 and central nervous system cancer: For instance, Transfection of miR-203 mimetics into U251 glioblastoma cells, which showed a decrease in miR-203 levels relative to less malignant gliomas or normal gliomas, led to inhibition of the PLD2 (phospholipase D2) oncogene, the target of miR-203.